News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
727,104 Results
Type
Article (51233)
Company Profile (331)
Press Release (675540)
Multimedia
Podcasts (66)
Webinars (12)
Section
Business (208983)
Career Advice (2037)
Deals (36039)
Drug Delivery (104)
Drug Development (84515)
Employer Resources (173)
FDA (16602)
Job Trends (15162)
News (354576)
Policy (33543)
Tag
Academia (2728)
Academic (1)
Accelerated approval (6)
Adcomms (26)
Allergies (86)
Alliances (51257)
ALS (92)
Alzheimer's disease (1391)
Antibody-drug conjugate (ADC) (151)
Approvals (16590)
Artificial intelligence (270)
Autoimmune disease (22)
Automation (16)
Bankruptcy (369)
Best Places to Work (11860)
BIOSECURE Act (21)
Biosimilars (107)
Biotechnology (245)
Bladder cancer (85)
Brain cancer (30)
Breast cancer (303)
Cancer (2422)
Cardiovascular disease (180)
Career advice (1702)
Career pathing (30)
CAR-T (164)
Cell therapy (452)
Cervical cancer (21)
Clinical research (68541)
Collaboration (869)
Company closure (1)
Compensation (537)
Complete response letters (25)
COVID-19 (2643)
CRISPR (46)
C-suite (254)
Cystic fibrosis (101)
Data (2238)
Decentralized trials (2)
Denatured (19)
Depression (44)
Diabetes (271)
Diagnostics (6647)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (126)
Drug pricing (106)
Drug shortages (25)
Duchenne muscular dystrophy (95)
Earnings (87721)
Editorial (39)
Employer branding (21)
Employer resources (147)
Events (116065)
Executive appointments (734)
FDA (17886)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (773)
Gene editing (113)
Generative AI (22)
Gene therapy (326)
GLP-1 (729)
Government (4536)
Grass and pollen (5)
Guidances (67)
Healthcare (19342)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (126)
Indications (29)
Infectious disease (2787)
Inflammatory bowel disease (141)
Inflation Reduction Act (9)
Influenza (51)
Intellectual property (97)
Interviews (316)
IPO (16778)
IRA (41)
Job creations (3732)
Job search strategy (1448)
Kidney cancer (11)
Labor market (38)
Layoffs (500)
Leadership (17)
Legal (8143)
Liver cancer (81)
Lung cancer (345)
Lymphoma (157)
Machine learning (7)
Management (58)
Manufacturing (315)
MASH (69)
Medical device (13491)
Medtech (13496)
Mergers & acquisitions (19799)
Metabolic disorders (698)
Multiple sclerosis (81)
NASH (16)
Neurodegenerative disease (91)
Neuropsychiatric disorders (29)
Neuroscience (1938)
NextGen: Class of 2025 (6742)
Non-profit (4660)
Now hiring (39)
Obesity (372)
Opinion (221)
Ovarian cancer (78)
Pain (89)
Pancreatic cancer (86)
Parkinson's disease (150)
Partnered (21)
Patents (240)
Patient recruitment (114)
Peanut (46)
People (58716)
Pharmaceutical (71)
Pharmacy benefit managers (18)
Phase I (21445)
Phase II (30057)
Phase III (22443)
Pipeline (1224)
Policy (144)
Postmarket research (2814)
Preclinical (9296)
Press Release (67)
Prostate cancer (113)
Psychedelics (32)
Radiopharmaceuticals (264)
Rare diseases (398)
Real estate (6068)
Recruiting (65)
Regulatory (23018)
Reports (46)
Research institute (2488)
Resumes & cover letters (352)
Rett syndrome (5)
RNA editing (5)
RSV (43)
Schizophrenia (70)
Series A (135)
Series B (86)
Service/supplier (12)
Sickle cell disease (56)
Special edition (16)
Spinal muscular atrophy (158)
Sponsored (31)
Startups (3748)
State (2)
Stomach cancer (16)
Supply chain (68)
Tariffs (41)
The Weekly (45)
Vaccines (723)
Venture capitalists (41)
Weight loss (242)
Women's health (35)
Worklife (16)
Date
Today (51)
Last 7 days (920)
Last 30 days (2653)
Last 365 days (33498)
2025 (11011)
2024 (36105)
2023 (40960)
2022 (52221)
2021 (56782)
2020 (55088)
2019 (47720)
2018 (35971)
2017 (33332)
2016 (32835)
2015 (38838)
2014 (32633)
2013 (28046)
2012 (30314)
2011 (30854)
2010 (29172)
Location
Africa (768)
Alabama (53)
Alaska (7)
Arizona (239)
Arkansas (13)
Asia (40198)
Australia (6756)
California (6245)
Canada (2030)
China (541)
Colorado (269)
Connecticut (281)
Delaware (149)
Europe (88725)
Florida (918)
Georgia (208)
Idaho (58)
Illinois (547)
India (25)
Indiana (311)
Iowa (11)
Japan (164)
Kansas (107)
Kentucky (25)
Louisiana (10)
Maine (62)
Maryland (917)
Massachusetts (4672)
Michigan (221)
Minnesota (397)
Mississippi (2)
Missouri (83)
Montana (30)
Nebraska (25)
Nevada (63)
New Hampshire (64)
New Jersey (1750)
New Mexico (29)
New York (1780)
North Carolina (995)
North Dakota (8)
Northern California (2709)
Ohio (205)
Oklahoma (14)
Oregon (38)
Pennsylvania (1399)
Puerto Rico (12)
Rhode Island (33)
South America (1150)
South Carolina (24)
South Dakota (1)
Southern California (2335)
Tennessee (102)
Texas (921)
United States (23569)
Utah (183)
Virginia (146)
Washington D.C. (62)
Washington State (571)
West Virginia (3)
Wisconsin (64)
727,104 Results for "cancer genetics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Myriad Genetics and Gabbi to Work Together to Increase Access to Hereditary Cancer Risk Assessment Tools
February 28, 2025
·
3 min read
Press Releases
Myriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual Meeting
April 25, 2025
·
6 min read
Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that Genetics in Medicine, an official journal of the American College of Medical Genetics and Genomics (ACMG), published a new study validating RiskScore®, Myriad’s breast cancer risk assessment tool integrated into its MyRisk® Hereditary Cancer Test.
June 3, 2024
·
4 min read
Press Releases
AccuStem Sciences, Inc. and EmeritusDX Announce Partnership to Commercialize MSC Test for Lung Cancer Screening
April 29, 2025
·
4 min read
Press Releases
Autonomix Medical, Inc. Reports Positive Outcomes in Initial Phase of First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain and Initiates Market Expansion Study for Visceral Cancer Pain
May 1, 2025
·
9 min read
Press Releases
Bexion Pharmaceuticals, Inc. Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2025
April 25, 2025
·
2 min read
Press Releases
Ensoma to Present Preclinical Data and Manufacturing Advancements for In Vivo HSC Engineering Platform to Treat Cancer, Immune Disorders and Genetic Diseases at ASGCT 28th Annual Meeting
April 29, 2025
·
5 min read
Press Releases
Alligator Bioscience Announces Initiation of HLX22 Phase 2 Trial in Breast Cancer by Shanghai Henlius Biotech, Inc.
April 23, 2025
·
1 min read
Bladder cancer
Pfizer’s Subcutaneous PD-1 Cuts Risks in Bladder Cancer but Misses Survival Endpoint
Pfizer’s sasanlimab, when used with standard of care, reduced the likelihood of disease recurrence or progression, death due to any cause or persistence of cancer cells by 32% in patients with high-risk non-muscle invasive bladder cancer.
April 28, 2025
·
1 min read
·
Tristan Manalac
Legal
BMS Scores Two on Tuesday With Colorectal Cancer Approval, Court Win
The FDA approved the use of Opdivo with Yervoy in front-line colorectal cancer, while a Manhattan court junked a class action complaint over the blood cancer drug Pomalyst.
April 9, 2025
·
2 min read
·
Tristan Manalac
1 of 72,711
Next
